AllNewsPhotosVideos
Bharat Biotech International

Bharat Biotech

Bharat biotech, Latest News

I'm sure approval of Covaxin from WHO will come at soonest possible, says FS Shringla - Hindi News | I'm sure approval of Covaxin from WHO will come at soonest possible, says FS Shringla | Latest national News at Lokmattimes.com

National :I'm sure approval of Covaxin from WHO will come at soonest possible, says FS Shringla

Foreign Secretary Harsh Vardhan Shringla on Thursday expressed hope that the World Health Organisation (WHO) will soon give approval to Hyderabad-based Bharat Biotech's COVID-19 vaccine Covaxin. ...

I'm sure approval of Covaxin from WHO will come at soonest possible, says FS Shringla - Hindi News | I'm sure approval of Covaxin from WHO will come at soonest possible, says FS Shringla | Latest national News at Lokmattimes.com

National :I'm sure approval of Covaxin from WHO will come at soonest possible, says FS Shringla

Foreign Secretary Harsh Vardhan Shringla on Thursday expressed hope that the World Health Organisation (WHO) will soon give approval to Hyderabad-based Bharat Biotech's COVID-19 vaccine Covaxin. ...

Covaxin's approval for children aged 2-18 yrs under experts' opinion, evaluation: Sources - Hindi News | Covaxin's approval for children aged 2-18 yrs under experts' opinion, evaluation: Sources | Latest national News at Lokmattimes.com

National :Covaxin's approval for children aged 2-18 yrs under experts' opinion, evaluation: Sources

The final approval for Bharat Biotech's Covaxin for children aged 2-18 years is under experts opinion and evaluation, stated Government sources on Thursday. ...

Awaiting regulatory approval for rolling out Covaxin for children aged 2-18 yrs, says Bharat Biotech - Hindi News | Awaiting regulatory approval for rolling out Covaxin for children aged 2-18 yrs, says Bharat Biotech | Latest national News at Lokmattimes.com

National :Awaiting regulatory approval for rolling out Covaxin for children aged 2-18 yrs, says Bharat Biotech

The Subject Expert Committee (SEC) has given a recommendation to the Drugs Controller General of India (DCGI) for the use of Bharat Biotech's COVID-19 vaccine, Covaxin, for the beneficiaries aged between 2-18 years, the official sources said on Tuesd ...

Covid vaccine for kids, teenagers can be 'a game changer', say experts - Hindi News | Covid vaccine for kids, teenagers can be 'a game changer', say experts | Latest health News at Lokmattimes.com

Health :Covid vaccine for kids, teenagers can be 'a game changer', say experts

New Delhi, Oct 12 Covid vaccinations for children and adolescents can turn out to be a game changer ... ...

Vax for children: Bharat Biotech awaits further regulatory approval - Hindi News | Vax for children: Bharat Biotech awaits further regulatory approval | Latest health News at Lokmattimes.com

Health :Vax for children: Bharat Biotech awaits further regulatory approval

Hyderabad, Oct 12 Vaccine maker Bharat Biotech on Tuesday said that it is awaiting further regulatory approval from ... ...

Approval to Covaxin for children aged between 2-18 years awaited after evaluation of data - Hindi News | Approval to Covaxin for children aged between 2-18 years awaited after evaluation of data | Latest national News at Lokmattimes.com

National :Approval to Covaxin for children aged between 2-18 years awaited after evaluation of data

After the evaluation of data Covaxin is yet to get approval by the Drugs Controller General of India (DCGI) for children between 2-18 years old, according to official sources. ...

Covaxin gets emergency use approval for kids aged 2-18 years - Hindi News | Covaxin gets emergency use approval for kids aged 2-18 years | Latest health News at Lokmattimes.com

Health :Covaxin gets emergency use approval for kids aged 2-18 years

New Delhi, Oct 12 The Hyderabad-based pharma major Bharat Biotech's Covaxin has got the emergency use approval for ... ...